ロード中...

Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia

Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1.7-hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human CNGB3 gene, for treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensit...

詳細記述

保存先:
書誌詳細
出版年:Hum Gene Ther Clin Dev
主要な著者: Ye, Guo-jie, Budzynski, Ewa, Sonnentag, Peter, Nork, T. Michael, Miller, Paul E., McPherson, Leslie, Ver Hoeve, James N., Smith, Leia M., Arndt, Tara, Mandapati, Savitri, Robinson, Paulette M., Calcedo, Roberto, Knop, David R., Hauswirth, William W., Chulay, Jeffrey D.
フォーマット: Artigo
言語:Inglês
出版事項: Mary Ann Liebert, Inc. 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4851180/
https://ncbi.nlm.nih.gov/pubmed/27003752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/humc.2015.163
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!